lobbying_activities: 1126459

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1126459	c42fffa4-154f-4ae8-a06f-0b3eaaf9c0b7	Q2	DOW LOHNES GOVERNMENT STRATEGIES LLC	316013	AMERISOURCEBERGEN CORPORATION	2011	second_quarter	PHA	H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree history, wholesale transaction documentation, and electronic tracking; Federal policy related to wet AMD pharmaceutical products and pricing.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2011-07-19T20:25:41.627000-04:00